Clinical Trials › NCT05849467
RecruitingPhase 1
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
Sponsored by National Institute of Neurological Disorders and Stroke (NINDS)
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 15
Target enrollment
1
U.S. states
Oct 2023
Start date
Jun 2026
Expected completion
Interventions / Treatments
89 Zr-Df-crefmirlimab
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Maryland1 site
Bethesda
MS centers in Maryland
Compare treatment centers near a trial site by center type, providers and trials.
View Maryland centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.